EP 1202988 A2 20020508 - NOVEL INTEGRIN RECEPTOR ANTAGONISTS
Title (en)
NOVEL INTEGRIN RECEPTOR ANTAGONISTS
Title (de)
NEUE ANTAGONISTEN VON INTEGRINREZEPTOREN
Title (fr)
NOUVEAUX ANTAGONISTES DES RECEPTEURS INTEGRINES
Publication
Application
Priority
- DE 19936780 A 19990809
- EP 0007440 W 20000801
Abstract (en)
[origin: US7105508B1] The invention relates to novel compounds which bind to integrin receptors, and to the preparation thereof and the use thereof as drugs.
IPC 1-7
C07D 401/12; A61K 31/55; A61P 43/00; C07D 401/14; C07D 213/73; C07D 403/12; C07D 491/04; C07D 409/14
IPC 8 full level
A61K 31/4402 (2006.01); A61K 31/55 (2006.01); A61K 31/5513 (2006.01); A61P 3/14 (2006.01); A61P 5/18 (2006.01); A61P 7/02 (2006.01); A61P 9/00 (2006.01); A61P 9/08 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 9/14 (2006.01); A61P 13/12 (2006.01); A61P 17/02 (2006.01); A61P 17/06 (2006.01); A61P 19/00 (2006.01); A61P 19/08 (2006.01); A61P 19/10 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 33/00 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); A61P 43/00 (2006.01); C07D 213/74 (2006.01); C07D 223/20 (2006.01); C07D 243/38 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07D 417/06 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 495/04 (2006.01); C07D 495/14 (2006.01)
CPC (source: EP KR US)
A61P 3/14 (2018.01 - EP); A61P 5/18 (2018.01 - EP); A61P 7/02 (2018.01 - EP); A61P 9/00 (2018.01 - EP); A61P 9/08 (2018.01 - EP); A61P 9/10 (2018.01 - EP); A61P 9/12 (2018.01 - EP); A61P 9/14 (2018.01 - EP); A61P 13/12 (2018.01 - EP); A61P 17/02 (2018.01 - EP); A61P 17/06 (2018.01 - EP); A61P 19/00 (2018.01 - EP); A61P 19/08 (2018.01 - EP); A61P 19/10 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 31/04 (2018.01 - EP); A61P 31/12 (2018.01 - EP); A61P 33/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 35/04 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07D 223/20 (2013.01 - EP KR US); C07D 243/38 (2013.01 - EP KR US); C07D 401/06 (2013.01 - EP KR US); C07D 401/12 (2013.01 - EP KR US); C07D 401/14 (2013.01 - EP US); C07D 403/12 (2013.01 - EP KR US); C07D 403/14 (2013.01 - EP US); C07D 409/12 (2013.01 - EP KR US); C07D 409/14 (2013.01 - EP KR US); C07D 417/06 (2013.01 - EP KR US); C07D 417/12 (2013.01 - EP KR US); C07D 417/14 (2013.01 - EP US); C07D 471/04 (2013.01 - EP KR US); C07D 495/04 (2013.01 - EP KR US); C07D 495/14 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
US 7105508 B1 20060912; AU 6990000 A 20010305; BG 106395 A 20021229; BR 0013265 A 20020514; CA 2379977 A1 20010215; CN 1374960 A 20021016; CZ 2002439 A3 20021113; DE 19936780 A1 20010215; EP 1202988 A2 20020508; HK 1049001 A1 20030425; HU P0204113 A2 20030428; HU P0204113 A3 20031128; IL 148043 A0 20020912; JP 2003506441 A 20030218; KR 20020019974 A 20020313; MX PA02001379 A 20020730; NO 20020644 D0 20020208; NO 20020644 L 20020318; PL 354193 A1 20031229; SK 2002002 A3 20021106; TR 200200357 T2 20020923; WO 0110847 A2 20010215; WO 0110847 A3 20011101; WO 0110847 A8 20011206
DOCDB simple family (application)
US 4926602 A 20020909; AU 6990000 A 20000801; BG 10639502 A 20020206; BR 0013265 A 20000801; CA 2379977 A 20000801; CN 00813099 A 20000801; CZ 2002439 A 20000801; DE 19936780 A 19990809; EP 0007440 W 20000801; EP 00958347 A 20000801; HK 03101187 A 20030218; HU P0204113 A 20000801; IL 14804300 A 20000801; JP 2001515313 A 20000801; KR 20027001861 A 20020209; MX PA02001379 A 20000801; NO 20020644 A 20020208; PL 35419300 A 20000801; SK 2002002 A 20000801; TR 200200357 T 20000801